ACI 39th Annual FDA Boot Camp
September 14, 2022

On September 14, Axinn partner Chad Landmon participated in a panel entitled, "Part 1 – Patents and Related IP Protections and Mechanisms" at American Conference Institute's 39th Annual FDA Boot Camp, held virtually September 14-15. 

The session covered several topics on patent protection for drugs and biologics including, summarizing the patenting process for drugs and biologics, distinguishing the patenting process for drugs from that of biologics, selecting a brand name for a proposed drug product, the branding process for drug products, and more. 

Click here for more information. 

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.